Skip to content

Codon Devices, founded in 2004, was a privately-held biotechnology company focused on enabling commercial applications of synthetic biology. The company’s proprietary synthesis and design technologies aimed to deliver high-value products and design services in a variety of application areas, including engineered gene libraries, engineered cells, improved vaccines, agricultural products, and biorefineries. Codon Devices ceased operations in 2009.